What is PolyPid Ltd.'s earnings per share (EPS)?

PolyPid Ltd. (PYPD) reported diluted earnings per share of $2.09 for fiscal year 2025. This represents a -57.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PolyPid Ltd. (PYPD) Financials

PYPD

FY2025 annual

Net Income -$34.2M -17.7% YoY

EPS (Diluted) $2.09 -57.4% YoY

Free Cash Flow -$28.1M -27.5% YoY

Operating Cash Flow -$27.9M -26.9% YoY

Market Cap $105.6M as of Oct 6, 2026

Price / Sales n/m no revenue reported

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book 9.6x on $11.0M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Feb 25, 2026 Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Feb 25, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PYPD SEC filings page.

This page shows PolyPid Ltd. (PYPD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

PolyPid Ltd. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

2/6

PolyPid Ltd. passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

N/A

PolyPid Ltd. reported a net loss of $34.2M while operations used $27.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

PolyPid Ltd. reported an operating loss of $33.0M against $874K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt

$6.4M

YoY-59.1%

QoQ-63.3%

PolyPid Ltd. held $6.4M in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding

18M

YoY+78.6%

QoQ+16.3%

PolyPid Ltd. had 18M shares outstanding in Q4 2025. This represents an increase of 78.6% from the same quarter a year earlier. Against the prior quarter it is up 16.3%.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

PYPD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PYPD quarterly income statement

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
R&D Expenses	$23.8M+4.4%	$22.8M+41.3%	$16.1M-42.3%	$28.0M-8.4%	$30.6M+80.2%	$17.0M+20.4%	$14.1M+12.2%	$12.6M
SG&A Expenses	$7.2M+68.1%	$4.3M-22.6%	$5.5M-31.0%	$8.0M-16.6%	$9.6M+24.7%	$7.7M+114.6%	$3.6M-31.8%	$5.3M
Operating Income	-$33.0M-17.6%	-$28.0M-22.6%	-$22.9M+41.2%	-$38.9M+9.9%	-$43.1M-64.2%	-$26.3M-41.6%	-$18.6M-1.1%	-$18.4M
EBITDA	-$31.5M-19.3%	-$26.4M-25.5%	-$21.0M+43.4%	-$37.2M+11.6%	-$42.0M-66.4%	-$25.3M-43.4%	-$17.6M+1.9%	-$18.0M
Interest Expense	$874K-42.1%	$1.5M-6.7%	$1.6M+58.2%	$1.0M	N/A	N/A	N/A	N/A
Income Tax	$5K-88.1%	$42K-39.1%	$69K-46.5%	$129K	N/A	N/A	N/A	N/A
Net Income	-$34.2M-17.7%	-$29.0M-21.6%	-$23.9M+39.7%	-$39.6M+7.1%	-$42.6M-15.5%	-$36.9M-433.9%	-$6.9M-216.7%	$5.9M
EPS (Basic)	$2.09-57.4%	$4.91-71.1%	$16.99-72.2%	$61.09-10.5%	$68.27+1423.9%	$4.48-81.1%	$23.69+14906.3%	-$0.16
EPS (Diluted)	$2.09-57.4%	$4.91	$16.93	$61.09-10.5%	$68.27+1423.9%	$4.48	$23.69+2654.7%	$0.86
Diluted Shares (Avg)	16M+176.5%	6M	1M	647,556+3.8%	624,051-93.5%	10M	562,451-8.3%	613,358

Metric	Q4'2520-F	Q2'256-K	Q4'2420-F	Q2'246-K	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q
R&D Expenses	N/A	$6.2M+30.6%	N/A	$4.8M+20.2%	N/A	$4.0M-52.8%	N/A	$8.4M+12.8%
SG&A Expenses	N/A	$2.5M+127.0%	N/A	$1.1M-27.1%	N/A	$1.5M-33.0%	N/A	$2.2M-8.4%
Operating Income	N/A	-$9.4M-53.6%	N/A	-$6.1M-5.2%	N/A	-$5.8M+49.7%	N/A	-$11.6M-8.8%
Income Tax	N/A	$53K+2550.0%	N/A	$2K-80.0%	N/A	$10K	N/A	N/A
Net Income	N/A	-$10.0M-58.5%	N/A	-$6.3M-7.8%	N/A	-$5.8M+50.7%	N/A	-$11.8M-13.1%
EPS (Basic)	N/A	$0.78-37.6%	N/A	$1.25-68.4%	N/A	$3.95+547.5%	N/A	$0.61+8.9%
EPS (Diluted)	N/A	$0.78	N/A	$1.25	N/A	$3.95	N/A	$0.61+8.9%
Diluted Shares (Avg)	N/A	13M	N/A	5M	N/A	1M	N/A	20M+4.0%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, EBITDA, Interest Expense.

PYPD Balance Sheet

PYPD quarterly balance sheet

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
Total Assets	$22.3M-11.6%	$25.2M+64.1%	$15.4M-40.8%	$26.0M-41.3%	$44.2M-41.7%	$75.8M+124.7%	$33.8M	N/A
Current Assets	$15.2M-8.1%	$16.6M+173.2%	$6.1M-57.3%	$14.2M-59.2%	$34.8M-26.2%	$47.2M+72.3%	$27.4M	N/A
Cash & Equivalents	$6.4M-59.1%	$15.6M+194.6%	$5.3M-37.9%	$8.6M-12.9%	$9.8M+127.3%	$4.3M+10.1%	$3.9M-49.5%	$7.8M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0-100.0%	$9.3M-21.0%	$11.8M+25.0%	$9.4M-67.1%	$28.6M+351.1%	$6.4M	$0
Total Liabilities	$11.3M-35.4%	$17.5M+0.4%	$17.5M-13.3%	$20.1M+143.4%	$8.3M+169.5%	$3.1M-97.5%	$121.4M	N/A
Current Liabilities	$7.7M-39.0%	$12.7M+74.0%	$7.3M-14.8%	$8.6M+5.9%	$8.1M+180.7%	$2.9M+11.6%	$2.6M	N/A
Non-Current Liabilities	$3.6M-26.0%	$4.9M-52.3%	$10.2M-12.1%	$11.6M+5723.6%	$199K+3.1%	$193K-99.8%	$118.8M	N/A
Long-Term Debt	N/A	$634K-90.1%	$6.4M-15.8%	$7.6M	N/A	N/A	N/A	N/A
Total Equity	$11.0M+42.8%	$7.7M+466.6%	-$2.1M-136.0%	$5.8M-83.8%	$36.0M-50.6%	$72.8M+183.0%	-$87.6M-7.2%	-$81.7M
Retained Earnings	-$301.5M-12.8%	-$267.3M-12.2%	-$238.3M-11.1%	-$214.4M-22.6%	-$174.9M-32.2%	-$132.3M-41.8%	-$93.3M	N/A

Metric	Q4'2520-F	Q2'256-K	Q4'2420-F	Q2'246-K	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q
Total Assets	$22.3M-11.6%	$37.7M+93.0%	$25.2M+64.1%	$19.5M-25.6%	$15.4M-40.8%	$26.3M-24.6%	$26.0M-41.3%	$34.8M-43.3%
Current Assets	$15.2M-8.1%	$30.0M+206.7%	$16.6M+173.2%	$9.8M-37.9%	$6.1M-57.3%	$15.8M-37.0%	$14.2M-59.2%	$25.0M-49.1%
Cash & Equivalents	$6.4M-59.1%	$17.4M+467.2%	$15.6M+194.6%	$3.1M-9.4%	$5.3M-37.9%	$3.4M-70.8%	$8.6M-12.9%	$11.6M+56.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0-100.0%	$0	$9.3M-21.0%	$0-100.0%	$11.8M+25.0%	$9.8M-19.8%
Total Liabilities	$11.3M-35.4%	$17.2M-4.0%	$17.5M+0.4%	$17.9M+0.1%	$17.5M-13.3%	$17.9M+14.1%	$20.1M+143.4%	$15.7M+248.2%
Current Liabilities	$7.7M-39.0%	$13.2M+27.9%	$12.7M+74.0%	$10.3M+88.7%	$7.3M-14.8%	$5.5M-37.4%	$8.6M+5.9%	$8.7M+101.4%
Non-Current Liabilities	$3.6M-26.0%	$4.1M-46.9%	$4.9M-52.3%	$7.6M-38.7%	$10.2M-12.1%	$12.5M+78.0%	$11.6M+5723.6%	$7.0M+3585.8%
Long-Term Debt	N/A	N/A	$634K-90.1%	$3.1M-63.4%	$6.4M-15.8%	$8.5M	$7.6M	N/A
Total Equity	$11.0M+42.8%	$20.5M+1179.0%	$7.7M+466.6%	$1.6M-80.8%	-$2.1M-136.0%	$8.3M-56.3%	$5.8M-83.8%	$19.1M-66.4%
Retained Earnings	-$301.5M-12.8%	-$285.6M-13.8%	-$267.3M-12.2%	-$251.1M-10.9%	-$238.3M-11.1%	-$226.3M-14.0%	-$214.4M-22.6%	-$198.6M-31.1%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.

PYPD Cash Flow Statement

PYPD quarterly cash flow statement

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
Operating Cash Flow	-$27.9M-26.9%	-$22.0M-27.4%	-$17.2M+49.8%	-$34.3M-6.0%	-$32.4M-50.0%	-$21.6M-24.4%	-$17.4M-4.1%	-$16.7M
Depreciation & Amortization	$1.5M-10.1%	$1.6M-11.0%	$1.8M+5.9%	$1.7M+53.9%	$1.1M+10.5%	$1.0M+6.9%	$947K+130.4%	$411K
Stock-Based Compensation	$4.9M+71.9%	$2.8M-16.7%	$3.4M-21.3%	$4.3M-9.3%	$4.8M+3.8%	$4.6M+369.0%	$976K-1.9%	$995K
Capital Expenditures	$210K+176.3%	$76K-61.2%	$196K-88.9%	$1.8M-33.4%	$2.7M+239.7%	$781K-11.1%	$879K-71.4%	$3.1M
Free Cash Flow	-$28.1M-27.5%	-$22.0M-26.4%	-$17.4M+51.7%	-$36.1M-3.0%	-$35.0M-56.6%	-$22.4M-22.7%	-$18.2M+7.7%	-$19.8M
Investing Cash Flow	-$6.7M-1931.5%	-$330K-108.7%	$3.8M-77.0%	$16.6M-55.1%	$36.9M+190.5%	-$40.8M-73.0%	-$23.6M-315.1%	$11.0M
Financing Cash Flow	$25.4M-21.7%	$32.4M+224.9%	$10.0M-39.3%	$16.4M+1488.8%	$1.0M-98.4%	$62.8M+66.7%	$37.7M+301.1%	$9.4M

Metric	Q4'2520-F	Q2'256-K	Q4'2420-F	Q2'246-K	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

PYPD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PYPD quarterly financial ratios

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K
Return on Equity	-311.4%+66.3pp	-377.7%	N/A	-678.6%-560.1pp	-118.5%-67.8pp	-50.7%	N/A	N/A
Return on Assets	-153.2%-38.1pp	-115.1%+40.2pp	-155.3%-2.9pp	-152.3%-56.0pp	-96.3%-47.7pp	-48.6%-28.1pp	-20.5%	N/A
Current Ratio	1.97+0.7x	1.31+0.5x	0.83-0.8x	1.66-2.7x	4.31-12.1x	16.41+5.8x	10.62	N/A
Debt-to-Equity	1.03+1.0x	0.08	N/A	1.30+1.1x	0.23+0.2x	0.04	N/A	N/A

Metric	Q4'2520-F	Q2'256-K	Q4'2420-F	Q2'246-K	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q
Return on Equity	N/A	-48.7%+344.4pp	N/A	-393.1%-323.2pp	N/A	-69.9%-8.0pp	N/A	-62.0%-43.6pp
Return on Assets	N/A	-26.5%+5.8pp	N/A	-32.2%-10.0pp	N/A	-22.2%+11.8pp	N/A	-34.0%-17.0pp
Current Ratio	1.97+0.7x	2.28+1.3x	1.31+0.5x	0.95-1.9x	0.83-0.8x	2.890.0x	1.66-2.7x	2.87-8.5x
Debt-to-Equity	1.03+1.0x	0.84-1.1x	0.08	1.95+0.9x	N/A	1.02+0.2x	1.30+1.1x	0.82+0.7x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
PolyPid Ltd. PYPD	FY2025	N/A	-$34.2M	N/A	$105.6M	—
Cue Biopharma, Inc. CUE	FY2025	$27.5M	-$26.6M	-96.9%	$185.8M	63/100
Karyopharm Therapeutics Inc. KPTI	FY2025	$146.1M	-$196.0M	N/A	$18.2M	54/100
CAMP4 Therapeutics Corporation CAMP	FY2025	$3.5M	-$80.4M	N/A	$251.0M	64/100
PDS Biotechnology Corporation PDSB	FY2025	N/A	-$34.5M	N/A	$54.2M	—
vTv Therapeutics Inc. VTVT	FY2025	$0	-$27.0M	N/A	$120.9M	—

Where PolyPid Ltd. Ranks

Frequently Asked Questions

Is PolyPid Ltd. profitable?

No, PolyPid Ltd. (PYPD) reported a net income of -$34.2M in fiscal year 2025.

What is PolyPid Ltd.'s EBITDA?

PolyPid Ltd. (PYPD) had EBITDA of -$31.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is PolyPid Ltd.'s return on equity (ROE)?

PolyPid Ltd. (PYPD) has a return on equity of -311.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is PolyPid Ltd.'s free cash flow?

PolyPid Ltd. (PYPD) recorded an outflow of $28.1M in free cash flow during fiscal year 2025. This represents a -27.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is PolyPid Ltd.'s operating cash flow?

PolyPid Ltd. (PYPD) recorded an outflow of $27.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are PolyPid Ltd.'s total assets?

PolyPid Ltd. (PYPD) had $22.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are PolyPid Ltd.'s capital expenditures?

PolyPid Ltd. (PYPD) invested $210K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does PolyPid Ltd. spend on research and development?

PolyPid Ltd. (PYPD) invested $23.8M in research and development during fiscal year 2025.

How many shares does PolyPid Ltd. have outstanding?

PolyPid Ltd. (PYPD) had 18M shares outstanding as of fiscal year 2025.

What is PolyPid Ltd.'s current ratio?

PolyPid Ltd. (PYPD) had a current ratio of 1.97 as of fiscal year 2025, which is generally considered healthy.

What is PolyPid Ltd.'s debt-to-equity ratio?

PolyPid Ltd. (PYPD) had a debt-to-equity ratio of 1.03 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is PolyPid Ltd.'s return on assets (ROA)?

PolyPid Ltd. (PYPD) had a return on assets of -153.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is PolyPid Ltd.'s P/E ratio?

PolyPid Ltd. (PYPD) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $105.6M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is PolyPid Ltd.'s price-to-sales ratio?

PolyPid Ltd. (PYPD) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $105.6M as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does PolyPid Ltd.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, PolyPid Ltd. (PYPD) held $6.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $27.9M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is PolyPid Ltd.'s Piotroski F-Score?

PolyPid Ltd. (PYPD) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are PolyPid Ltd.'s earnings high quality?

PolyPid Ltd. (PYPD) reported a net loss of $34.2M while operations used $27.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can PolyPid Ltd. cover its interest payments?

PolyPid Ltd. (PYPD) reported an operating loss of $33.0M against $874K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.